BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 21540015)

  • 1. No end in sight: the skin cancer epidemic continues.
    Donaldson MR; Coldiron BM
    Semin Cutan Med Surg; 2011 Mar; 30(1):3-5. PubMed ID: 21540015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence estimate of nonmelanoma skin cancer in the United States, 2006.
    Rogers HW; Weinstock MA; Harris AR; Hinckley MR; Feldman SR; Fleischer AB; Coldiron BM
    Arch Dermatol; 2010 Mar; 146(3):283-7. PubMed ID: 20231499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence Estimate of Nonmelanoma Skin Cancer (Keratinocyte Carcinomas) in the U.S. Population, 2012.
    Rogers HW; Weinstock MA; Feldman SR; Coldiron BM
    JAMA Dermatol; 2015 Oct; 151(10):1081-6. PubMed ID: 25928283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of a history of skin cancer in 2007: results of an incidence-based model.
    Stern RS
    Arch Dermatol; 2010 Mar; 146(3):279-82. PubMed ID: 20231498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonmelanoma skin carcinoma in Albuquerque, New Mexico: experience of a major health care provider.
    Hoy WE
    Cancer; 1996 Jun; 77(12):2489-95. PubMed ID: 8640697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology of nonmelanoma skin cancer.
    Strom SS; Yamamura Y
    Clin Plast Surg; 1997 Oct; 24(4):627-36. PubMed ID: 9342506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology of nonmelanoma skin cancer: a review.
    Corona R
    Ann Ist Super Sanita; 1996; 32(1):37-42. PubMed ID: 8804184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent trends in incidence of nonmelanoma skin cancers in the East of Scotland, 1992-2003.
    Brewster DH; Bhatti LA; Inglis JH; Nairn ER; Doherty VR
    Br J Dermatol; 2007 Jun; 156(6):1295-300. PubMed ID: 17535229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skin cancer trends in Northern Ireland and consequences for provision of dermatology services.
    Hoey SE; Devereux CE; Murray L; Catney D; Gavin A; Kumar S; Donnelly D; Dolan OM
    Br J Dermatol; 2007 Jun; 156(6):1301-7. PubMed ID: 17535230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends of nonmelanoma skin cancer from 1960 through 2000 in a Canadian population.
    Demers AA; Nugent Z; Mihalcioiu C; Wiseman MC; Kliewer EV
    J Am Acad Dermatol; 2005 Aug; 53(2):320-8. PubMed ID: 16021129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology and economic burden of nonmelanoma skin cancer.
    Cakir BÖ; Adamson P; Cingi C
    Facial Plast Surg Clin North Am; 2012 Nov; 20(4):419-22. PubMed ID: 23084294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First and subsequent nonmelanoma skin cancers: incidence and predictors in a population of New Zealand renal transplant recipients.
    Mackenzie KA; Wells JE; Lynn KL; Simcock JW; Robinson BA; Roake JA; Currie MJ
    Nephrol Dial Transplant; 2010 Jan; 25(1):300-6. PubMed ID: 19783601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of non-melanoma skin cancer in a national cohort of veterans with rheumatoid arthritis.
    Amari W; Zeringue AL; McDonald JR; Caplan L; Eisen SA; Ranganathan P
    Rheumatology (Oxford); 2011 Aug; 50(8):1431-9. PubMed ID: 21415022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence and prediction of nonmelanoma skin cancer post-renal transplantation: a prospective study in Queensland, Australia.
    Carroll RP; Ramsay HM; Fryer AA; Hawley CM; Nicol DL; Harden PN
    Am J Kidney Dis; 2003 Mar; 41(3):676-83. PubMed ID: 12612993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonmelanoma skin cancer after liver transplantation. Study of risk factors.
    Herrero JI; España A; Quiroga J; Sangro B; Pardo F; Alvárez-Cienfuegos J; Prieto J
    Liver Transpl; 2005 Sep; 11(9):1100-6. PubMed ID: 16123952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mohs micrographic surgery and surgical excision for nonmelanoma skin cancer treatment in the Medicare population.
    Viola KV; Jhaveri MB; Soulos PR; Turner RB; Tolpinrud WL; Doshi D; Gross CP
    Arch Dermatol; 2012 Apr; 148(4):473-7. PubMed ID: 22508870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonmelanoma skin cancer.
    Kim RH; Armstrong AW
    Dermatol Clin; 2012 Jan; 30(1):125-39, ix. PubMed ID: 22117874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in incidence of nonmelanoma skin cancers in Alberta, Canada, 1988-2007.
    Jung GW; Metelitsa AI; Dover DC; Salopek TG
    Br J Dermatol; 2010 Jul; 163(1):146-54. PubMed ID: 20645981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Skin cancer, rheumatoid arthritis, and tumor necrosis factor inhibitors.
    Chakravarty EF; Michaud K; Wolfe F
    J Rheumatol; 2005 Nov; 32(11):2130-5. PubMed ID: 16265690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seven-year prospective study of nonmelanoma skin cancer incidence in U.K. renal transplant recipients.
    Ramsay HM; Reece SM; Fryer AA; Smith AG; Harden PN
    Transplantation; 2007 Aug; 84(3):437-9. PubMed ID: 17700173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.